ONCOS-102 drug page Clinical trials

Trials with ONCOS-102

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
0Recruiting
1Countries
67Planned patients

Showing 1–1 of 1

A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
Finished Phase 1 67 patients NCT02963831

This is a two-part Phase 1/2 dose escalation and dose expansion study of an Adenovirus Vector (Ad5/3-D24-GMCSF), Expressing GM-CSF (GM-CSF-encoding adenovirus), ONCOS-102, in combination with anti-programmed death ligand-1 (PD-L1) antibody…

United States Sept 2017 – Jun 2022 Interventional